STAT

Delivering the TB vaccine by IV better protects monkeys, new study finds

A simple tweak could make a century-old vaccine for tuberculosis far more effective — but making the change could prove difficult in practice.

A new study suggests that a simple tweak could make a century-old vaccine for tuberculosis far more effective — but that shift could prove difficult in practice.

Researchers found that increasing the dose of a TB vaccine and delivering it intravenously better protected monkeys against the infection than the standard method, of injecting the vaccine into the skin. The scientists reported their findings Wednesday in Nature.

“By just changing the route of vaccination, we see an incredible protection against TB,” said Dr. Maziar Divangahi, who studies TB and vaccines at McGill University and was not involved in the new research.

“The question is can we ever do IV vaccination [with the TB vaccine] in

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks